Sabra Healthcare REIT (NASDAQ:SBRA) Releases FY 2026 Earnings Guidance

Sabra Healthcare REIT (NASDAQ:SBRA) updated its FY 2026 earnings guidance on Wednesday. The company provided earnings per share guidance of 1.550-1.590 for the period, compared to the consensus earnings per share estimate of 1.500. The company issued revenue guidance of -.

Analyst Ratings Changes

A number of brokerages have recently commented on SBRA. Cantor Fitzgerald raised their target price on shares of Sabra Healthcare REIT from $20.00 to $21.00 and gave the company a “neutral” rating in a research note on Tuesday, February 17th. Truist Financial increased their price target on Sabra Healthcare REIT from $21.00 to $22.00 and gave the company a “hold” rating in a report on Friday, March 13th. Weiss Ratings raised Sabra Healthcare REIT from a “buy (b+)” rating to a “buy (a-)” rating in a research report on Wednesday, March 18th. Wells Fargo & Company boosted their price objective on Sabra Healthcare REIT from $21.00 to $22.00 and gave the stock an “overweight” rating in a research note on Thursday, March 26th. Finally, Citigroup upped their target price on Sabra Healthcare REIT from $21.00 to $24.00 and gave the stock a “buy” rating in a research report on Wednesday, February 18th. One investment analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and five have given a Hold rating to the company. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $22.00.

Sabra Healthcare REIT Stock Down 0.8%

Shares of SBRA traded down $0.16 during mid-day trading on Wednesday, reaching $20.35. 5,379,229 shares of the stock traded hands, compared to its average volume of 2,582,003. The stock has a fifty day simple moving average of $20.21 and a 200 day simple moving average of $19.32. Sabra Healthcare REIT has a 12-month low of $17.04 and a 12-month high of $21.07. The company has a quick ratio of 4.29, a current ratio of 4.29 and a debt-to-equity ratio of 0.90. The firm has a market cap of $5.13 billion, a price-to-earnings ratio of 31.80, a P/E/G ratio of 1.62 and a beta of 0.67.

Sabra Healthcare REIT (NASDAQ:SBRA) last announced its earnings results on Wednesday, April 29th. The real estate investment trust reported $0.39 earnings per share for the quarter, beating the consensus estimate of $0.16 by $0.23. Sabra Healthcare REIT had a net margin of 20.09% and a return on equity of 5.63%. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. Sell-side analysts expect that Sabra Healthcare REIT will post 1.5 EPS for the current fiscal year.

Sabra Healthcare REIT Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, February 27th. Shareholders of record on Friday, February 13th were given a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a yield of 5.9%. The ex-dividend date of this dividend was Friday, February 13th. Sabra Healthcare REIT’s dividend payout ratio is presently 187.50%.

Institutional Trading of Sabra Healthcare REIT

Hedge funds and other institutional investors have recently modified their holdings of the business. PharVision Advisers LLC acquired a new stake in Sabra Healthcare REIT during the 3rd quarter valued at approximately $280,000. Corient Private Wealth LLC purchased a new stake in Sabra Healthcare REIT during the 4th quarter worth approximately $266,000. NewEdge Advisors LLC raised its position in shares of Sabra Healthcare REIT by 1,189.1% in the 3rd quarter. NewEdge Advisors LLC now owns 14,180 shares of the real estate investment trust’s stock valued at $264,000 after purchasing an additional 13,080 shares in the last quarter. Lido Advisors LLC acquired a new position in shares of Sabra Healthcare REIT in the 3rd quarter valued at approximately $256,000. Finally, Militia Capital Partners LP purchased a new position in shares of Sabra Healthcare REIT during the 4th quarter valued at approximately $246,000. 99.40% of the stock is owned by hedge funds and other institutional investors.

About Sabra Healthcare REIT

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net?lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long?term, triple?net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post?acute rehabilitation and research and development laboratories.